Evidence map›Paper›PMID 34654357›Full record

ArticleBioengineered2021

Circular RNA FOXP1 relieves trophoblastic cell dysfunction in recurrent pregnancy loss via the miR-143-3p/S100A11 cascade.

Yuan Gao, Yukun Tang, Qian Sun, Guixue Guan, Xiaoyan Wu, Fan Shi, Zihao Zhou, Wen Yang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The Role of Placental Non-Coding RNAs in Adverse Pregnancy Outcomes.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Circular RNAs in Pregnancy and the Placenta.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuan GaoDepartment of Gynecology, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.
Yukun TangDepartment of Ultrasound, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.
Qian SunDepartment of Gynecology, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.
Guixue GuanDepartment of Gynecology, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.
Xiaoyan WuDepartment of Gynecology, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.
Fan ShiDepartment of Gynecology, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.
Zihao ZhouDepartment of Clinical Medicine, Nanjing Medical University, Nanjing, P.R. China.
Wen YangDepartment of Gynecology, The First People's Hospital of Lianyungang, Lianyungang, P.R. China.ORCID 0000-0001-8113-0269
The First People’s Hospital of Lianyungang · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent pregnancy loss (RPL) is closely associated with insufficient functions of trophoblastic cells. Circular RNA forkhead box P1 (circFOXP1) can regulate cell activities in different types of diseases. However, its effects on trophoblastic cells and its role in RPL development remain unknown. In this study, gene expressions were detected by RT-qPCR. Protein levels were detected by Western blotting. Trophoblastic cell viability, apoptosis, invasion, and migration were respectively analyzed via CCK-8, flow cytometry, wound healing, and transwell assays. The association between miR-143-3p and circFOXP1 or S100A11 (S100 calcium binding protein A11) was explored and confirmed by bioinformatics prediction and luciferase reporter assay. Herein, miR-143-3p was upregulated in RPL. Furthermore, miR-143-3p upregulation induced apoptosis and suppressed proliferation, epithelial-to-mesenchymal transition (EMT) process, and metastatic capabilities of trophoblastic cells; whereas, miR-143-3p inhibition exert opposite effects. MiR-143-3p targeted S100A11 and was adversely regulated by circFOXP1 expression. S100A11 inhibition partially offset the effect of miR-143-3p knockdown on trophoblastic cell viability, apoptosis, EMT, invasion, and migration. In addition, circFOXP1 competitively combined with miR-143-3p, thus regulating S100A11 expression. Moreover, circFOXP1 regulated trophoblastic cell functions through the miR-143-3p/S100A11 cascade. To sum up, our study, for the first time, demonstrated that circFOXP1 could improve dysfunction of trophoblastic cells through the miR-143-3p/S100A11 axis, providing novel biomarkers and diagnostic targets for RPL.

Indexed as

Gene Expression RegulationAbortion, HabitualCase-Control StudiesCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleForkhead Transcription FactorsHumansMicroRNAsPregnancyRepressor ProteinsRNA, CircularS100 ProteinsTrophoblastsForkhead Transcription FactorsFOXP1 protein, humanMicroRNAsMIRN143 microRNA, humanRepressor ProteinsRNA, CircularS100A11 protein, humanS100 ProteinsCircfoxp1epithelial-to-mesenchymal transitionmiR–143–3precurrent pregnancy lossS100A11

Identifiers

PMID34654357
PMCPMC8806990
OpenAlexW3207499711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.